GlassScriptPhysician profile
William Kyle Wilson
NPI 1316384316
$46,160.81
in general payments reported to CMS, 2019-2025
15 companies · $74.58 in 2025
The $74.58 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $155 · 2021: $176 · 2022: $1,846 · 2023: $2,346 · 2024: $99.12 · 2025: $74.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,756 · Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,756.26 |
| Food and Beverage | $763.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $26,708.04 | 2019 | |
| Smith+Nephew, INC. | $10,429.13 | 2019-2025 | Coblation, Ultrabutton, Q-Fix |
| Exactech, INC. | $3,064.48 | 2019-2023 | |
| Medinc of Texas | $2,685.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,404.58 | 2019 | |
| Alon Medical Technology | $1,312.00 | 2019 | |
| Stryker Corporation | $171.17 | 2019-2021 | |
| Horizon Therapeutics Plc | $146.87 | 2019-2020 | |
| Fx Shoulder Solutions, INC | $99.12 | 2024 | |
| Welch Allyn | $33.45 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $28.20 | 2025 | |
| Vericel Corporation | $21.56 | 2025 | Maci |
| Depuy Synthes Sales INC. | $21.26 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $18.35 | 2022 | |
| Baxter Healthcare | $17.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.